Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial

Brian I. Rini; Michael B. Atkins; Elizabeth R. Plimack; Denis Soulières; Raymond S. McDermott; Jens Bedke; Sophie Tartas; Boris Alekseev; Bohuslav Melichar; Yaroslav Shparyk; Chihiro Kondoh; Przemyslaw Langiewicz; Lori A. Wood; Hans Hammers; Cynthia G. Silber; Barbara Haber; Erin Jensen; Mei Chen; Thomas Powles

doi:10.1016/j.euo.2021.05.007

Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial

Brian I. Rini, Michael B. Atkins, Elizabeth R. Plimack, Denis Soulières, Raymond S. McDermott, Jens Bedke, Sophie Tartas, Boris Alekseev, Bohuslav Melichar, Yaroslav Shparyk, Chihiro Kondoh, Przemyslaw Langiewicz, Lori A. Wood, Hans Hammers, Cynthia G. Silber, Barbara Haber, Erin Jensen, Mei Chen, Thomas Powles

科研成果: 期刊稿件 › 文章 › 同行评审

18 引用（Scopus）

源语言	英语
页（从-至）	225-234
页数	10
期刊	European urology oncology
卷	5
期	2
DOI	https://doi.org/10.1016/j.euo.2021.05.007
出版状态	已出版 - 4月 1 2022
已对外发布	是

!!!ASJC Scopus Subject Areas

一般医学

访问文件

10.1016/j.euo.2021.05.007

其它文件与链接

引用此

Rini, B. I., Atkins, M. B., Plimack, E. R., Soulières, D., McDermott, R. S., Bedke, J., Tartas, S., Alekseev, B., Melichar, B., Shparyk, Y., Kondoh, C., Langiewicz, P., Wood, L. A., Hammers, H., Silber, C. G., Haber, B., Jensen, E., Chen, M., & Powles, T. (2022). Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial. European urology oncology, 5(2), 225-234. https://doi.org/10.1016/j.euo.2021.05.007

Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial. / Rini, Brian I.; Atkins, Michael B.; Plimack, Elizabeth R. 等.
在: European urology oncology, 卷 5, 号码 2, 01.04.2022, 页码 225-234.

科研成果: 期刊稿件 › 文章 › 同行评审

Rini, BI, Atkins, MB, Plimack, ER, Soulières, D, McDermott, RS, Bedke, J, Tartas, S, Alekseev, B, Melichar, B, Shparyk, Y, Kondoh, C, Langiewicz, P, Wood, LA, Hammers, H, Silber, CG, Haber, B, Jensen, E, Chen, M & Powles, T 2022, 'Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial', European urology oncology, 卷 5, 号码 2, 页码 225-234. https://doi.org/10.1016/j.euo.2021.05.007

@article{6ef92617b1be46ab9d0080c67b60995f,

title = "Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial",

author = "Rini, {Brian I.} and Atkins, {Michael B.} and Plimack, {Elizabeth R.} and Denis Souli{\`e}res and McDermott, {Raymond S.} and Jens Bedke and Sophie Tartas and Boris Alekseev and Bohuslav Melichar and Yaroslav Shparyk and Chihiro Kondoh and Przemyslaw Langiewicz and Wood, {Lori A.} and Hans Hammers and Silber, {Cynthia G.} and Barbara Haber and Erin Jensen and Mei Chen and Thomas Powles",

note = "Publisher Copyright: Copyright {\textcopyright} 2021. Published by Elsevier B.V.",

year = "2022",

month = apr,

day = "1",

doi = "10.1016/j.euo.2021.05.007",

language = "English",

volume = "5",

pages = "225--234",

journal = "European urology oncology",

issn = "2588-9311",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial

AU - Rini, Brian I.

AU - Atkins, Michael B.

AU - Plimack, Elizabeth R.

AU - Soulières, Denis

AU - McDermott, Raymond S.

AU - Bedke, Jens

AU - Tartas, Sophie

AU - Alekseev, Boris

AU - Melichar, Bohuslav

AU - Shparyk, Yaroslav

AU - Kondoh, Chihiro

AU - Langiewicz, Przemyslaw

AU - Wood, Lori A.

AU - Hammers, Hans

AU - Silber, Cynthia G.

AU - Haber, Barbara

AU - Jensen, Erin

AU - Chen, Mei

AU - Powles, Thomas

PY - 2022/4/1

Y1 - 2022/4/1

UR - http://www.scopus.com/inward/record.url?scp=85130001872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130001872&partnerID=8YFLogxK

U2 - 10.1016/j.euo.2021.05.007

DO - 10.1016/j.euo.2021.05.007

M3 - Article

C2 - 34244116

AN - SCOPUS:85130001872

SN - 2588-9311

VL - 5

SP - 225

EP - 234

JO - European urology oncology

JF - European urology oncology

IS - 2

ER -

Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此